CG Oncology’s $140 Million Agreement with Kissei Pharmaceutical

Wilson Sonsini Goodrich & Rosati represented CG Oncology in the transaction. CG Oncology, Inc. has announced an exclusive license, development and commercialization agreement with Kissei Pharmaceutical…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now